Understanding the five mistakes to avoid in order to ensure brand success
Authored by Maxine Smith, Managing Director, Uptake Strategies for the PME Pharma Strategists’ Blog
In this article for Pharma Market Europe, Maxine shares her five ‘deadly sins’ to avoid when considering the competitive landscape. She explores in detail how our view of competitive threat – whether taken too seriously, or not seriously enough – can impact upon the effectiveness of our strategy.
Maxine warns pharma brands not to get complacent by relying on the strength of early data and the clear differentiated positioning carved out at launch stage. She encourages constant exploration and evaluation to reinforce the strength of positioning, and how this can be woven into the fabric of disease management.
